RT Journal Article SR Electronic T1 Mental Disorder Prevalence Among Populations Impacted by Coronavirus Pandemics: A Multilevel Meta-Analytic Study of COVID-19, MERS & SARS JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.12.18.20248499 DO 10.1101/2020.12.18.20248499 A1 Matt Boden A1 Nichole Cohen A1 Jessilyn M. Froelich A1 Katherine J. Hoggatt A1 Hoda S. Abdel Magid A1 Swapandeep S. Mushiana YR 2020 UL http://medrxiv.org/content/early/2020/12/22/2020.12.18.20248499.abstract AB Coronavirus pandemics are associated with a number of well-documented threats, stressors and traumas that vary by impacted population and contribute to mental disorders. Through a systematic review and meta-analysis of research on COVID-19, severe acute respiratory syndrome (SARS) and middle east respiratory syndrome (MERS) pandemics, we investigated whether mental disorder prevalence: (a) was elevated among populations impacted by coronavirus pandemics (relative to unselected populations reported in the literature), and (b) varied by disorder (undistinguished psychiatric morbidity, anxiety, depressive, posttraumatic stress disorders [PTSD]) and impacted population (community, infected/recovered, healthcare provider, quarantined). From 60 publications (N=66,190 participants), 725 individual estimates were included in a series of multilevel meta-analyses/regressions including random effects to account for estimates nested within studies. Across disorder and population, the median summary point prevalence was 20% (95%CI=17-25%). Prevalence estimates were generally substantially higher than reported by prior research for unselected samples. Psychiatric morbidity and PTSD were most prevalent in most populations. The highest prevalence of each disorder was found among infected/recovered adults. Notably high prevalence was found for (a) psychiatric morbidity, PTSD and depression in infected/recovered adults (25-56%), (b) psychiatric morbidity and PTSD in healthcare providers (21-29%), (c) depression and PTSD in the adults in the community (15-19%), and (d) psychiatric morbidity in quarantined adults (28%). Sensitivity analyses demonstrated that overall prevalence estimates were higher for studies/estimates: (1) focused on SARS or MERS versus COVID-19, (2) conducted in Hong Kong or Korea versus other locations, obtained (3) via questionnaire versus clinician assessment and (4) with standard versus non-standard scoring, and (5) of moderate or very low versus low quality. The number of mental disorders attributable to COVID-19 will be substantial and magnitudes higher than attributable to MERS and SARS due to the vast scope and ongoing nature of the COVID-19 pandemic.Competing Interest StatementMatt Boden consulted for Beneath the Surface Foundation.Funding StatementNone.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/A. This was a secondary data analysis of publicly available data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available upon request of the first author.